Liminatus Pharma Files 8-K
Ticker: LIMNW · Form: 8-K · Filed: Jun 24, 2025 · CIK: 1971387
| Field | Detail |
|---|---|
| Company | Liminatus Pharma, Inc. (LIMNW) |
| Form Type | 8-K |
| Filed Date | Jun 24, 2025 |
| Risk Level | low |
| Sentiment | neutral |
Sentiment: neutral
Topics: 8-K, disclosure, financials
TL;DR
Liminatus Pharma filed an 8-K on 6/23/25. Standard disclosure.
AI Summary
Liminatus Pharma, Inc. filed an 8-K on June 23, 2025, reporting other events and financial statements. The company, formerly Iris Parent Holding Corp., is incorporated in Delaware and operates in the biological products sector. Its principal executive offices are located in La Palma, California.
Why It Matters
This filing indicates a routine corporate update and disclosure of financial information for Liminatus Pharma, Inc., providing transparency to investors.
Risk Assessment
Risk Level: low — This is a standard 8-K filing for reporting events and financial statements, with no immediate indication of significant risk.
Key Players & Entities
- Liminatus Pharma, Inc. (company) — Registrant
- Iris Parent Holding Corp. (company) — Former Company Name
- June 23, 2025 (date) — Date of earliest event reported
- La Palma, CA (location) — Principal Executive Offices
FAQ
What is the primary purpose of this 8-K filing for Liminatus Pharma, Inc.?
The 8-K filing reports 'Other Events' and 'Financial Statements and Exhibits' as of June 23, 2025.
When was the earliest event reported in this filing?
The earliest event reported is dated June 23, 2025.
What was Liminatus Pharma, Inc.'s former company name?
Liminatus Pharma, Inc.'s former company name was Iris Parent Holding Corp.
In which state is Liminatus Pharma, Inc. incorporated?
Liminatus Pharma, Inc. is incorporated in Delaware.
What is the business address of Liminatus Pharma, Inc.?
The business address is 6 Centerpointe Drive #625, La Palma, CA 90623.
Filing Details
This Form 8-K (Form 8-K) was filed with the SEC on June 24, 2025 regarding Liminatus Pharma, Inc. (LIMNW).